Victor G. Matassa

2.3k citations

60 papers · 1.8k indexed · h-index 26

Hepatology top 1%
- Hepatitis C virus research 19
Virology top 5%
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 8
Pharmaceutical Science top 2%
Organic Chemistry top 5%
- Asymmetric Synthesis and Catalysis 7
Cellular and Molecular Neuroscience
- Neuropeptides and Animal Physiology 12
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 12
Oncology
- Peptidase Inhibition and Analysis 9
Molecular Biology
- Biochemical and Molecular Research 7
Epidemiology
- Hepatitis B Virus Studies 6

Co-authors: Raffaele De Francesco Uwe Koch Frank Narjes Sergio Altamura Stefania Colarusso Vincenzo Summa José L. Castro Alessia Petrocchi
Cited by: Hepatology Virology Infectious Diseases
Journals: Journal of Biological Chemistry (2 papers)Journal of Molecular Biology (1 paper)Biochemistry (1 paper)
Partner nations: Italy United States United Kingdom

In The Last Decade

Victor G. Matassa

58 papers receiving 1.7k citations

Peers

Countries citing papers authored by Victor G. Matassa

Since Specialization

Citations

This map shows the geographic impact of Victor G. Matassa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor G. Matassa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor G. Matassa more than expected).

Fields of papers citing papers by Victor G. Matassa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor G. Matassa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor G. Matassa. The network helps show where Victor G. Matassa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Victor G. Matassa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Victor G. Matassa Line = papers co-authored together Victor G. Matassa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Indolin-2-one p38α inhibitors III: Bioisosteric amide replacement Bioorganic & Medicinal Chemistry Letters ·Paul Eastwood,Jacob González,Elena Gómez,Francisco Caturla,Núria Aguilar,Marta Mir,Josep Aiguadé,Victor G. Matassa,Cristina Balagué,Adelina Orellana,María Domínguez	2011	30
2	From lead to preclinical candidate: Optimization of β-homophenylalanine based inhibitors of dipeptidyl peptidase IV Bioorganic & Medicinal Chemistry Letters ·Sonja Nordhoff,Meritxell López-Canet,Barbara Hoffmann-Enger,Stephan Bulat,Silvia Cerezo-Gálvez,Oliver Hill,Claudia Rosenbaum,Christian Rummey,Meinolf Thiemann,Victor G. Matassa,Paul Edwards,Achim Feurer	2009	8
3	Discovery of β-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV Bioorganic & Medicinal Chemistry Letters ·Sonja Nordhoff,Silvia Cerezo-Gálvez,H. Deppe,Oliver Hill,Meritxell López-Canet,Christian Rummey,Meinolf Thiemann,Victor G. Matassa,Paul Edwards,Achim Feurer	2009	13
4	The design of potent and selective inhibitors of DPP-4: Optimization of ADME properties by amide replacements Bioorganic & Medicinal Chemistry Letters ·Sonja Nordhoff,Stephan Bulat,Silvia Cerezo-Gálvez,Oliver Hill,Barbara Hoffmann-Enger,Meritxell López-Canet,Claudia Rosenbaum,Christian Rummey,Meinolf Thiemann,Victor G. Matassa,Paul Edwards,Achim Feurer	2009	21
5	SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease Bioorganic & Medicinal Chemistry Letters ·Savina Malancona,Stefania Colarusso,Jesus M. Ontoria,Antonella Marchetti,Marco Poma,Ian Stansfield,Ralph Laufer,Annalise Di Marco,Marina Taliani,Maria Verdirame,Odalys Gonzalez-Paz,Victor G. Matassa,Frank Narjes	2004	20
6	The monoethyl ester of meconic acid is an active site inhibitor of HCV NS5B RNA-dependent RNA polymerase Bioorganic & Medicinal Chemistry Letters ·Paola Pace,Emanuela Nizi,Barbara Pacini,Silvia Pesci,Victor G. Matassa,Raffaele De Francesco,Sergio Altamura,Vincenzo Summa	2004	39
7	Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease Bioorganic & Medicinal Chemistry Letters ·Emanuela Nizi,Uwe Koch,Jesus M. Ontoria,Antonella Marchetti,Frank Narjes,Savina Malancona,Victor G. Matassa,Cristina Gardelli	2004	13
8	Novel, potent phenethylamide inhibitors of the hepatitis C virus (HCV) NS3 protease: probing the role of P2 aryloxyprolines with hybrid structures Bioorganic & Medicinal Chemistry Letters ·Federica Orvieto,Uwe Koch,Victor G. Matassa,Ester Muraglia	2003	25
9	Capped dipeptide α-Ketoacid inhibitors of the HCV NS3 protease Bioorganic & Medicinal Chemistry Letters ·Emanuela Nizi,Uwe Koch,Simona Ponzi,Victor G. Matassa,Cristina Gardelli	2002	12
10	Evolution, synthesis and SAR of tripeptide α-ketoacid Inhibitors of the hepatitis C virus NS3/NS4A serine protease Bioorganic & Medicinal Chemistry Letters ·Stefania Colarusso,Benjamin Gerlach,Uwe Koch,Ester Muraglia,Immacolata Conte,Ian Stansfield,Victor G. Matassa,Frank Narjes	2002	40
11	Inhibition of the Hepatitis C Virus NS3/4A Protease Journal of Biological Chemistry ·Stefania Di Marco,Menico Rizzi,Cinzia Volpari,Martin Walsh,Frank Narjes,Stefania Colarusso,Raffaele De Francesco,Victor G. Matassa,Maurizio Sollazzo	2000	107
12	Probing the Active Site of the Hepatitis C Virus Serine Protease by Fluorescence Resonance Energy Transfer Journal of Biological Chemistry ·Daniela Fattori,Andrea Urbani,Mirko Brunetti,Raffaele Ingenito,Antonello Pessi,Kristine Prendergast,Frank Narjes,Victor G. Matassa,Raffaele De Francesco,Christian Steinkühler	2000	18
13	Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies Journal of Molecular Biology ·Daniel O. Cicero,Gaetano Barbato,Uwe Koch,Paolo Ingallinella,Elisabetta Bianchi,Maria Chiara Nardi,Christian Steinkühler,Riccardo Cortese,Victor G. Matassa,Raffaele De Francesco,Antonello Pessi,Renzo Bazzo	1999	48
14	Controlled Modification of Acidity in Cholecystokinin B Receptor Antagonists: N-(1,4-Benzodiazepin-3-yl)-N ‘-[3-(tetrazol-5-ylamino)phenyl]ureas Journal of Medicinal Chemistry ·José L. Castro,Richard G. Ball,Howard B. Broughton,Michael G. N. Russell,Denise Rathbone,Alan P. Watt,Raymond Baker,Kerry L. Chapman,Alan E. Fletcher,Smita S. Patel,Alison J. Smith,George Marshall,Wayne Ryecroft,Victor G. Matassa	1996	59
15	L‐694,247: a potent 5‐HT_1Dreceptor agonist British Journal of Pharmacology ·Margaret S. Beer,Josephine A. Stanton,Yvette Bevan,Anne Heald,A. J. REEVE,Leslie J. Street,Victor G. Matassa,Richard Hargreaves,Derek N. Middlemiss	1993	45
16	Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptors Journal of Medicinal Chemistry ·Leslie J. Street,R. BAKER,José L. Castro,Mark S. Chambers,Alexander R. Guiblin,Sarah C. Hobbs,Victor G. Matassa,Austin J. Reeve,Margaret S. Beer	1993	62
17	L-708,474: The C5-cyclohexyl analogue of L-365,260, a selective high affinity ligand for the CCKB/gastrin receptor Bioorganic & Medicinal Chemistry Letters ·Mark S. Chambers,Sarah C. Hobbs,Stephen R. Fletcher,Victor G. Matassa,Paul J. Mitchell,Alan P. Watt,Raymond Baker,Ben Freedman,Smita S. Patel,Alison J. Smith	1993	25
18	Synthesis and in vitro LTD4 antagonist activity of bicyclic and monocyclic cyclopentylurethane and cyclopentylacetamide N-arylsulfonyl amides Journal of Medicinal Chemistry ·Victor G. Matassa,F.J. Brown,Peter R Bernstein,Howard Shapiro,Thomas Maduskuie,Laura A. Cronk,Edward P. Vacek,Ying K. Yee,David W. Snyder	1990	16
19	The Preclinical Pharmacology of ICI 204,219: A Peptide Leukotriene Antagonist American Review of Respiratory Disease ·Robert D. Krell,David Aharony,Carl K. Buckner,Richard A. Keith,Edward J. Kusner,David W. Snyder,Peter R Bernstein,Victor G. Matassa,Ying K. Yee,Fred J. Brown,Barrie Hesp,Ralph E. Giles	1990	132
20	Synthesis of 4,4-disubstituted cyclohexenones. Part 3. The reaction of 1,3-bis(trimethylsilyloxy)cyclohexa-1,3-dienes with dienophiles. An unexpected rearrangement of the adducts from the reaction with 2-chloroacrylonitrile Journal of the Chemical Society Perkin Transactions 1 ·Richard S. J. Clark,Andrew B. Holmes,Victor G. Matassa	1990	3

About Victor G. Matassa

Victor G. Matassa is a scholar working on Hepatology, Cellular and Molecular Neuroscience and Organic Chemistry, having authored 60 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (19 papers), Neuropeptides and Animal Physiology (12 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Peptidase Inhibition and Analysis (9 papers), HIV/AIDS drug development and treatment (8 papers), Biochemical and Molecular Research (7 papers), Asymmetric Synthesis and Catalysis (7 papers) and Hepatitis B Virus Studies (6 papers). The work is most often cited by research in Hepatology (547 citations), Virology (129 citations) and Infectious Diseases (456 citations). Victor G. Matassa has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Raffaele De Francesco, Uwe Koch, Frank Narjes, Sergio Altamura, Stefania Colarusso, Vincenzo Summa, José L. Castro, Alessia Petrocchi, Christian Steinkühler and Paola Pace. Their work appears in journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact